Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Ellagitannins from pomegranates, primarily punicalagin, are hydrolyzed into ellagic acid and further metabolized by gut microbiota into urolithins. These compounds exert anti-inflammatory, antioxidant, and antiproliferative effects by modulating pathways such as NF-κB and Nrf2.
Reported Benefits (Provisional)
Origin & History
Ellagitannins are polyphenolic compounds abundantly found in Punica granatum, commonly known as pomegranate, particularly in the fruit’s peel and seeds. Native to the Middle East and Indian subcontinent, pomegranates have been cultivated for millennia. These compounds are renowned for their powerful antioxidant and anti-inflammatory properties. When consumed, ellagitannins are metabolized into urolithins, bioactive compounds that enhance their therapeutic potential for functional nutrition.
Research Narrative (Provisional)
Research on ellagitannins from pomegranates includes in vitro, animal, and some human clinical trials, primarily focusing on their antioxidant, anti-inflammatory, and cardiovascular benefits. Studies suggest potential in modulating gut microbiota and exhibiting anti-proliferative effects in various cancer models. While promising, more large-scale human randomized controlled trials are needed to solidify specific health claims.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Ellagitannins: Punicalagins (A and B), punicalin, gallagic acid, ellagic acid. - Urolithins: Bioactive metabolites (e.g., urolithin A, B, C, D) formed in the gut. - Polyphenols: Diverse array of compounds contributing to antioxidant and anti-inflammatory effects.
Reported Mechanism (Provisional)
Ellagitannins, particularly ellagic acid and its urolithin metabolites, inhibit matrix metalloproteinase-9 (MMP-9) secretion and expression by suppressing the NF-κB pathway. They also directly block NF-κB and activate Nrf2, mediating significant anti-inflammatory and antioxidant responses. Furthermore, these compounds can induce cell cycle arrest in G0/G1 and G2/M phases, contributing to antiproliferative effects.
Clinical Narrative (Provisional)
Research on pomegranate ellagitannins encompasses in vitro, animal, and some human clinical trials, consistently demonstrating their antioxidant and anti-inflammatory benefits. Studies indicate potential for improving cardiovascular function by enhancing blood vessel elasticity and modulating lipid profiles, as well as supporting gut microbiota balance through urolithin production. Furthermore, investigations suggest antiproliferative effects, particularly in vitro, warranting further human clinical exploration.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.